Concepedia

James L. Weemhoff

JL

Statistics

Publications

16

Citations

782

H-Index

15

Active since

2002

Affiliations

University of Kansas Medical Center(Current)

Tufts Medical Center

Tufts University

St David's Medical Center

University of Liverpool

James L. Weemhoff is an author at University of Kansas Medical Center specializing in pharmacology, acetaminophen-induced liver necrosis, and hepatotoxicity mechanisms.

ORCID

Publications per year

2002–2023

16

Publications

16

Inhibition of human cytochromes P450 by components of <i>Ginkgo biloba</i>

Lisa L. von Moltke, James L. Weemhoff, Ikhlas A. Khan et al. · Journal of Pharmacy and Pharmacology · 2004 · 154 citations · Full text

, , +12

Biomarkers distinguish apoptotic and necrotic cell death during hepatic ischemia/reperfusion injury in mice

Min Yang, Daniel J. Antoine, James L. Weemhoff et al. · Liver Transplantation · 2014 · 92 citations · Full text

, , +17

Editor’s Highlight: Metformin Protects Against Acetaminophen Hepatotoxicity by Attenuation of Mitochondrial Oxidant Stress and Dysfunction

Kuo Du, Anup Ramachandran, James L. Weemhoff et al. · Toxicological Sciences · 2016 · 72 citations · Full text

, , +17

Mito-tempo protects against acute liver injury but induces limited secondary apoptosis during the late phase of acetaminophen hepatotoxicity

Kuo Du, Anup Ramachandran, James L. Weemhoff et al. · Archives of Toxicology · 2018 · 63 citations

, , +17

Differential susceptibility to acetaminophen-induced liver injury in sub-strains of C57BL/6 mice: 6N versus 6J

Luqi Duan, John S. Davis, Benjamin L. Woolbright et al. · Food and Chemical Toxicology · 2016 · 53 citations

, , +15

1–5 of 16